Neuraxpharm Boosts Branded Business With Established Sanofi Portfolios
Latest Acquisition Should See Firm’s Annual Gross Sales Expand To €600m
Executive Summary
CNS specialist Neuraxpharm has purchased two of Sanofi’s product portfolios, substantially expanding the number of branded products it has to offer.